🟢 Generate Biomedicines is trading 11.45% up today amid a broad risk-on rebound

Generate Biomedicines is trading 11.45% up at $17.48, moving with a broad risk-on rebound rather than a clearly disclosed company-specific catalyst.

• Biotech is gaining 2.55%, while the S&P 500, Nasdaq Composite, and Dow Jones are also higher.
• Recent investor-conference appearances highlighted Generate Biomedicines’ AI platform, asthma program, and broader pipeline, but no new September 17 announcement directly explains the move.